this event will discuss emerging research relating...

This event will discuss emerging research relating to the physiology, psychology and pharmacology of

pain, and its assessment and management.

This event has CPD accreditation

www.lifescienceevents.com/pain2016

#PainESC

http://euroscicon.com/cpd-2

https://twitter.com/hashtag/PainESC

3 EuroSciCon Ltd. Registered in England and Wales, Company number: 4326921, Trading Address: Euroscicon Ltd, Highstone House, 165 High Street, Barnet, Herts.

EN5 5SU, UK. Registered Office: 47 High Street, Barnet, Herts, EN5 5UW, UK

Contents

Day 1: Pathophysiology of Pain............................................................................................................... 5

First Session ............................................................................................................................................ 5

Euroscicon Welcome ............................................................................................................................... 5

Introduction by the chair ........................................................................................................................ 5

Where is pain in the brain? ..................................................................................................................... 5

Oral Presentation .................................................................................................................................... 5

The roles of Clathrin Heavy Chain-22 in human pain and touch development ...................................... 5

Q and A .................................................................................................................................................... 5


Physical pain threshold and tolerance in self-harm: methodological challenges and future directions 5

Day 1: Pathophysiology of Pain............................................................................................................... 6

Second Session ........................................................................................................................................ 6



Talk title to be confirmed ........................................................................................................................ 6


Gentian Violet: A Potential Treatment For Cutaneous Leishmaniasis .................................................... 6


Targeting mRNA translation regulation to alleviate nociceptor plasticity driving chronic pain ............. 6

Central GABA-C receptors and anti-nociception .................................................................................... 6

Day 2: Pain Assessment & Diagnosis ...................................................................................................... 7

First Session ............................................................................................................................................ 7




The use of animal models to elucidate the pathophysiology of “dysfunctional pain”, an unexplained

and formidable pain category ................................................................................................................. 7



Brain electrophysiological representation of multidimensional subjective experience of pain during

noxious laser heat stimulation ................................................................................................................ 7

Day 2: Pain Assessment & Diagnosis ...................................................................................................... 8

Second Session ........................................................................................................................................ 8





Phantom limb pain in lower limb amputees: a discussion of the potential mechanisms ...................... 8



Behavioural pain assessment tool development and the development and initial testing of a meta

tool .......................................................................................................................................................... 8

Conceptual framework of pain in persons with mild traumatic brain injury/concussion ...................... 8

Q and A .................................................................................................................................................... 8

Day 3: Pain Management ........................................................................................................................ 9

First Session ............................................................................................................................................ 9



What are the effects of therapeutic play intervention on children’s perioperative anxiety, negative

emotional behaviour, and postoperative pain? ..................................................................................... 9

Morphine - P2Y12 inhibitors, a drug-drug interaction in STEMI patients .............................................. 9

Talk tittle to be confirmed ...................................................................................................................... 9



The impact of baroreflex sensitivity for the treatment of chronic pain. ................................................ 9

Day 3: Pain Management ...................................................................................................................... 10

Second Session ...................................................................................................................................... 10

Euroscicon Welcome ............................................................................................................................. 10

Introduction by the chair ...................................................................................................................... 10

Talk title to be confirmed ...................................................................................................................... 10

Chronic Pain Among Opioid Addiction Patients: Identifying and Managing an Important Risk Factor 10

Oral Presentation .................................................................................................................................. 10

Design of Novel Multivalent Ligands for the Treatment of Prolonged and Neuropathic Pain Without

the Development of Addiction and Other Toxicities ............................................................................ 10

Adapting the cancer pain management paradigm to non-cancer pain and survivorship .................... 10



Day 1: Pathophysiology of Pain

London GMT

New York EDT

Tokyo JST

First Session

07:15 03:15 16:15 Session online

Speaker practice session Poster Viewing

07:45 03:45 16:45 Euroscicon Welcome Euroscicon Host

07:50 03:50 16:50 Introduction by the chair

Where is pain in the brain? Q and A

Professor Emeritus Amos D Korczyn, Tel Aviv University, Ramat, Israel

08:45 04:45 17:45 Oral Presentation Speaker to be confirmed

09:00 05:00 18:00 Session break Poster Viewing

09:30 05:30 18:30 Disconnecting pain - neurosurgical treatments for intractable oncological pain Q and A

Dr. Ido Strauss, Tel Aviv University, Ramat Aviv, Tel Aviv, Israel

10:00 06:00 19:00 The roles of Clathrin Heavy Chain-22 in human pain and touch development Q and A

Dr. Mike Nahorski, University of Cambridge, Cambridge, United Kingdom


10:45 06:45 19:45 Session Break Poster Viewing

11:15 07:15 20:15 Gonadal Hormones and Pain Q and A

Professor Anna Maria Aloisi, Università degli Studi di Siena, Siena, Italy

11:45 07:45 20:45 Physical pain threshold and tolerance in self-harm: methodological challenges and future directions Q and A

Dr. Olivia J. Kirtley, University of Glasgow, Glasgow, United Kingdom

12:15 08:15 21:15 Closing remarks, End of Early Session Closing remarks, End of Early Session

http://www.dsmcn.unisi.it/it/dipartimento/personale/docenti/aloisi-anna-maria

https://sites.google.com/site/suicidalbehaviourresearchlab/



Day 1: Pathophysiology of Pain

London GMT

New York EDT

Tokyo JST

Second Session

13:15 09:15 22:15 Session online Speaker practice session Poster Viewing


13:50 09:50 22:50 Introduction by the chair

Talk title to be confirmed Q and A

Dr. Luana Colloca, University of Maryland School of Nursing University of Maryland School of Medicine, Baltimore, United States

14:30 10:30 23:30 Talk title to be confirmed Q and A

Dr. Yang D.Teng, Harvard Medical School, Boston, United States


15:30 11:30 00:30 Gentian Violet: A Potential Treatment For Cutaneous Leishmaniasis Q and A

Dr Marc Karam, University of Balamand, Biology Department, Kourah, Lebanon

16:00 12:00 01:00 Decreasing Tumor Necrosis Factor-alpha Solely in the Brain for Treatment of Neuropathic Pain Q and A

Professor Tracey A. Ignatowski, University at Buffalo, Buffalo, United States



17:15 13:15 02:15 Targeting mRNA translation regulation to alleviate nociceptor plasticity driving chronic pain Q and A

Dr. Theodore Price, University of Texas at Dallas, Richardson, United States

17:45 13:45 02:45 Inpatient headache managament for migraines and chronic daily headaches Q and A

Dr. Priyanka Chaudhry, Baylor Comprehensive Headache Center, Dallas, United States

18:15 14:15 03:15 Central GABA-C receptors and anti-nociception Q and A

Professor Sastry Bhagavatula, The University of British Columbia, Vancouver, Canada

18:45 14:45 03:45 Closing remarks, End of Late Session

http://www.utdallas.edu/~tjp140130/



Day 2: Pain Assessment & Diagnosis

London GMT

New York EDT

Tokyo JST

First Session




07:50 03:50 16:50 Introduction by the chair Dr. Tasha Stanton, The University of South Australia, School of Health Science, Adelaide, Australia


Dr. Ramakrishnan Mani, University of Otago, Dunedin, New Zealand

08:30 04:30 17:30 Where does the pain come from in osteoarthritis? Q and A

Professor Graeme Jones, University of Tasmania, Hobart TAS, Australia


09:30 05:30 18:30 Thinking outside of the joint: The role of the brain in osteoarthritic pain and stiffness Q and A

Dr. Tasha Stanton, The University of South Australia, School of Health Science, Adelaide, Australia

10:00 06:00 19:00 The use of animal models to elucidate the pathophysiology of “dysfunctional pain”, an unexplained and formidable pain category Q and A

Dr. Yukinori Nagakura, Aomori University, Aomori, Japan




Dr. Mary Ann Muckaden, Tata Memorial Centre, Mumbai, India

11:45 07:45 20:45 Brain electrophysiological representation of multidimensional subjective experience of pain during noxious laser heat stimulation Q and A

Dr. Andrej Stancak, University of Liverpool, Liverpool, United Kingdom

12:15 08:15 21:15 Closing remarks, End of Early Session

http://people.unisa.edu.au/Tasha.Stanton

http://www.pharmacotherapy.sakura.ne.jp/En_Index.html



Day 2: Pain Assessment & Diagnosis

London GMT

New York EDT

Tokyo JST

Second Session



13:50 09:50 22:50 Introduction by the chair Dr Cliff Richardson, University of Manchester, Manchester, United Kingdom

14:00 10:00 23:00 Phantom limb pain in lower limb amputees: a discussion of the potential mechanisms

Dr. Cliff Richardson, University of Manchester, Manchester, United Kingdom


Dr Rhiannon Worrall, Burton Hospital, Staffordshire, United Kingdom



16:00 12:00 01:00 Behavioural pain assessment tool development and the development and initial testing of a meta tool Q and A

Dr. Julie Gregory, University of Manchester, Manchester, United Kingdom

16:30 12:30 01:30 Conceptual framework of pain in persons with mild traumatic brain injury/concussion Q and A

Dr. Tatyana Mollayeva, University of Toronto, Toronto, Canada


http://www.nursing.manchester.ac.uk/staff/cliffrichardson/



Day 3: Pain Management

London GMT

New York EDT

Tokyo JST

First Session




07:50 03:50 16:50 Introduction by the chair Dr Ferenc Zádor, Hungarian Academy of Sciences, Szeged, Hungary

08:00 04:00 17:00 What are the effects of therapeutic play intervention on children’s perioperative anxiety, negative emotional behaviour, and postoperative pain? Q and A

Dr. He Hong-Gu, National University of Singapore, Singapore

08:30 04:30 17:30 Novel morphine analogue 14-O-methylmorphine with high mu opioid receptor agonist efficacy, selectivity and affinity Q and A

Dr Ferenc Zádor, Hungarian Academy of Sciences, Szeged, Hungary


09:30 05:30 18:30 Morphine - P2Y12 inhibitors, a drug-drug interaction in STEMI patients Q and A

Professor Jacek Kubica, Nicolaus Copernicus University, Collegium Medicum, Bydgoszcz, Poland

10:00 06:00 19:00 Talk tittle to be confirmed Q and A

Speaker to be confirmed




Dr. Eleni Besi, Eastman Dental Hospital, UCLH NHS Foundation Trust, United Kingdom

12:15 08:15 21:15 The impact of baroreflex sensitivity for the treatment of chronic pain.

Dr. Kati Thieme, Philipps-University of Marburg, Marburg, Germany

12:45 08:45 21:45 Closing remarks, End of Early Session



Day 3: Pain Management

London GMT

New York EDT

Tokyo JST

Second Session



13:50 09:50 22:50 Introduction by the chair Chair to be confirmed

14:00 10:00 23:00 Role of 6TM-mOR and GPCR heterodimerization in opioid induced hyperalgesia Q and A

Dr. Marino Convertino, University of North Carolina, United States


Dr. Felipe Fregni, Harvard Medical School, United States


15:30 11:30 00:30 Chronic Pain Among Opioid Addiction Patients: Identifying and Managing an Important Risk Factor Q and A

Dr. Zainab Samaan, McMaster University, Hamilton, Canada

16:00 12:00 01:00 Chronic Pain and Addiction: the Crossroads

Q and A

Dr. Peter Przekop, Loma Linda University, Loma Linda, United States



17:15 13:15 02:15 Design of Novel Multivalent Ligands for the Treatment of Prolonged and Neuropathic Pain Without the Development of Addiction and Other Toxicities Q and A

Dr. Victor J. Hruby, Regents Professor, Department of Chemistry and Biochemistry, University of Arizona, Tucson, AZ, USA

17:45 13:45 02:45 Adapting the cancer pain management paradigm to non-cancer pain and survivorship Q and A

Dr. Pippa Hawley, BC Cancer Agency, Vancouver, Canada


dokhlab.org

http://fhs.mcmaster.ca/ceb/faculty_member_samaan.htm



MEDIA SPONSORS

Missing Speakers

It is unfortunate that occasionally a speaker cannot attend. Whilst we do everything possible to ensure that our speakers are present at the event we apologise in advance if you were at a session where a speaker could not attend. We always try to keep our agendas as up to date as possible, however if a speaker cancels the night before an event or on the day, there is little we can do to rectify this.

this event will discuss emerging research relating...

Documents